Update on contraception: benefits and risks of the new formulations.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12959393.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Several new contraceptives have become available to women in recent years. These new agents include ultra-low-dose oral contraceptives as well as injectable, vaginal, and patch formulations. We review these, with emphasis on the Yasmin pill (which contains a new progestin), the Lunelle once-a-month injection, the Ortho Evra patch, the NuvaRing vaginal ring, the Mirena intrauterine device, and emergency contraceptive kits. Patient education regarding these options is essential for patient compliance and satisfaction.